Irreducible analogs of mevaldic acid coenzyme A hemithioacetal as potential inhibitors of HMG-CoA reductase. Synthesis of a carbon-sulfur interchanged analog of mevaldic acid pantetheine hemithioacetal
Irreducible analogs of mevaldic acid coenzyme A hemithioacetal as potential inhibitors of HMG-CoA reductase. Synthesis of a carbon-sulfur interchanged analog of mevaldic acid pantetheine hemithioacetal
Acyl-CoA: cholesterol O-acyl transferase (ACAT) inhibitors. 1. 2-(Alkylthio)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT
作者:Neil V. Harris、Andrew W. Bridge、Raymond C. Bush、Edward C. J. Coffee、Donald I. Dron、Mark F. Harper、Michael J. Ashton、David J. Lythgoe、Christopher Smith
DOI:10.1021/jm00101a016
日期:1992.11
potent, bioavailable ACAT inhibitor may have beneficial effects in the treatment of atherosclerosis by (i) reducing the absorption of dietary cholesterol, (ii) reducing the secretion of very low density lipoproteins into plasma from the liver, and (iii) preventing the transformation of arterial macrophages into foam cells. We have found that a mevalonate derivative 2, which contains a 4,5-diphenyl-1H-imidazol-2-yl
A diastereoselective synthesis of 4(RS), 6(SR)-mercaptomethylmevalonolactone, a key intermediate in the preparation of a new class of inhibitors of HMG-CoA reductase
作者:H. Ferres、I.K. Hatton、L.J.A. Jennings、A.W.R. Tyrrell、D.J. Williams
DOI:10.1016/s0040-4039(00)94530-1
日期:1983.1
EP0519996A1
申请人:——
公开号:EP0519996A1
公开(公告)日:1992-12-30
[EN] IMIDAZOLES
申请人:RHONE-POULENC RORER LIMITED
公开号:WO1991013876A1
公开(公告)日:1991-09-19
(EN) Imidazole derivates of general formula (II) in which R1 is hydrogen or one or more substituents, k is 0, 1 or 2, Q is a straight or branched alkylene group and Z is hydrogen or a substituent group and pharmaceutically acceptable salts thereof possess useful pharmacological properties as inhibitors of acyl coenzyme-A: cholesterol-o-acyl transferase and as inhibitors of the binding of thromboxane TXA2 to its receptors, and are useful in therapy.(FR) On décrit des dérivés d'imidazoles de formule générale (II) dans laquelle R1 est hydrogène ou un ou plusieurs substituants, k représente 0, 1 ou 2, Q est un groupe d'alkylène droit ou ramifié et z est hydrogène ou un groupe de substitution, ainsi que leurs sels pharmaceutiquement acceptables. Lesdits dérivés possèdent des propriétés pharmacologiques utiles en tant qu'inhibiteurs de la coenzyme-A d'acyle: cholestérol-0-acyle transférase et en tant qu'inhibiteurs de la liaison de thromboxane TXA2 à ses récepteurs, et ils sont également utiles dans les traitements.